<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01969656</url>
  </required_header>
  <id_info>
    <org_study_id>2MD-3H-1B/C</org_study_id>
    <nct_id>NCT01969656</nct_id>
  </id_info>
  <brief_title>Safety Study of an Oral Vitamin D Analog in Postmenopausal Women</brief_title>
  <official_title>A Phase 1B, Double-Blind, Placebo-Controlled, Calcitriol Active-Controlled, Daily-Dose, Escalating-Dose, Safety and Tolerance Study of 2MD Soft Gel Capsules in Normal Healthy Postmenopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deltanoid Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deltanoid Pharmaceuticals</source>
  <brief_summary>
    <textblock>
      Determine the safety of 2MD, a vitamin D analog, when administered orally once daily for 28
      days in healthy normal postmenopausal women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <primary_completion_date type="Actual">June 2004</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <primary_outcome>
    <measure>Change from baseline in total serum calcium</measure>
    <time_frame>Days 0 (pre-dose), 1, 2, 3, 7, 14, 21, 27, 28 and 2 weeks after last dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in levels of 2MD in the blood</measure>
    <time_frame>1, 2, 3, 12, 18 and 24 h after the initial dose on Day 0 and after the final dose on Day 27</time_frame>
  </primary_outcome>
  <number_of_arms>7</number_of_arms>
  <condition>Postmenopausal Osteoporosis, Multiple Sites</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcitriol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>50 ng 2MD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>110 ng 2MD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>170 ng 2MD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>220 ng 2MD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>440 ng 2MD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2MD</intervention_name>
    <arm_group_label>50 ng 2MD</arm_group_label>
    <arm_group_label>110 ng 2MD</arm_group_label>
    <arm_group_label>170 ng 2MD</arm_group_label>
    <arm_group_label>220 ng 2MD</arm_group_label>
    <arm_group_label>440 ng 2MD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcitriol</intervention_name>
    <arm_group_label>Calcitriol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Normal healthy postmenopausal women, ≥ 60 but ≤ 80 years of age, or between 45 and 60
             years of age who have been amenorrheic for at least 2 years plus have a serum FSH
             level of &gt; 30 IU/L, or women with a documented bilateral oophorectomy at least 2 years
             prior to study start.

          2. Within ±30% of their ideal body weight for height and body frame.

          3. Demonstrated ability to understand and willingness to sign an Informed Consent Form.

          4. 24-hour urinary Ca ≤250 mg/day and a urinary Ca:Cr ≤0.35.

          5. Negative urine test for selected drugs of abuse.

          6. Willing to maintain a total calcium intake between 700 and 1000 mg/day.

        Exclusion Criteria:

          1. Any acute or chronic condition that would limit the subject's ability to complete the
             study.

          2. Active clinical manifestations of significant metabolic, hematological, pulmonary,
             hepatic, cardiovascular, gastrointestinal (including malabsorption), neurological,
             renal, urological or psychiatric disorders.

          3. History or presence of any diseases known or believed to influence calcium absorption
             or metabolism.

          4. History of renal calculi.

          5. History of an eating disorder.

          6. History of stomach or intestinal surgery.

          7. History of hypersensitivity or allergies to any vitamin D derivative.

          8. History or presence of an abnormal ECG.

          9. Use of any medications or products affecting vitamin D metabolism within 6 months
             prior to study entry.

         10. Use of any medications or products affecting calcium balance or bone turnover within 6
             months prior to study entry.

         11. Participation in any other investigational study drug trial in which receipt of
             investigational study drug occurred within 60 days prior to study entry.

         12. Use of vitamin and/or mineral supplements &gt;1X RDI within 4 weeks prior to study entry,
             unless deemed acceptable by Investigator.

         13. Poor peripheral venous access.

         14. Receipt of blood products within 2 months prior to study entry.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2013</study_first_submitted>
  <study_first_submitted_qc>October 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2013</study_first_posted>
  <last_update_submitted>July 25, 2017</last_update_submitted>
  <last_update_submitted_qc>July 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D analog</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Osteoporosis, Postmenopausal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Calcitriol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

